NCT05333250View on ClinicalTrials.gov

Modafinil to Improve Fatiguability

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Cancer-related Cognitive DifficultiesCancer-related Problem/ConditionFatigue
Interventions
DRUG

Modafinil

Modafinil

OTHER

Placebo

Placebo

Trial Locations (1)

Unknown

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
collaborator

The Ottawa Hospital

OTHER

collaborator

Bruyère Health Research Institute.

OTHER

lead

Ottawa Hospital Research Institute

OTHER